Capstone Asset Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
SCM
CIP
CRM
Capstone Asset Management's CNMD Position: Q2 2017 in Review
Capstone Asset Management reduced its CONMED (CNMD) stake by 7.1% in Q2 2017, selling an estimated $19.8K and leaving 5,226 shares worth $266K. The position accounts for 0.01% of the portfolio, ranked #1347.
Capstone Asset Management first reported a position in CNMD in Q2 2013 and has held it in 17 quarters since. The position peaked at $630K in Q1 2015. 150 funds tracked by Wall St. Rank hold CNMD as of Q2 2017.
- Capstone Asset Management held 5,226 shares of CONMED worth $266K as of Q2 2017.
- Capstone Asset Management sold 400 CONMED shares in Q2 2017, an estimated $19.8K.
- CONMED made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1347 holding.
- Capstone Asset Management first reported a position in CONMED in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's CONMED position peaked at $630K in Q1 2015.
- 150 funds tracked by Wall St. Rank held CONMED as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.